An outbreak of acute fascioliasis among aymara indians in the bolivian altiplano

Clinical Infectious Diseases

Volumn 21, Issue 5, 1995, Pages 1228-1234

  Bjorland, Jostein ^a,b,c   Bryan, Ralph T ^a,b,c   Strauss, Wilma ^a,b,c   Hillyer, George V ^a,b,c   Mc Auley, James B ^a,b,c  

^a Instituto Nacional de Laboratorios de Salud Bolivia   (Bolivia)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; DISEASE TRANSMISSION; EPIDEMIC; FASCIOLA HEPATICA; FASCIOLIASIS; HUMAN; INDIAN; INFECTION PREVENTION; PATIENT EDUCATION; PLANT; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANIMAL; ANTIBODIES, HELMINTH; BOLIVIA; CASE-CONTROL STUDIES; CATTLE; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DISEASE OUTBREAKS; FASCIOLA HEPATICA; FASCIOLIASIS; FEMALE; HUMAN; IMMUNOGLOBULIN G; INDIANS, SOUTH AMERICAN; MALE; MIDDLE AGE; PLANTS; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 85047700189     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/21.5.1228     Document Type: Article

References (28)

1. Dawes B, Hughes DL. Fascioliasis: the invasive stages in mammals. Adv Parasitol 1970;8:259-74.
2. Chen MG, Mott KE. Progress in assessment of morbidity due to Fasciola hepatica infection: a review of recent literature. Trop Dis Bull 1990; 87(4)(suppl):Rl -R38.
3. Hardman EW, Jones RLH, Davies AH. Fascioliasis-a large outbreak. Br Med J 1970;3:502-5.
4. Schiappacasse RH, Mohammadi D, Christie AJ. Successful treatment of severe infection with Fasciola hepatica with praziquantel. J Infect Dis 1985;152:1339-40.
5. Bannerman C, Manzur AY. Fluctuating jaundice and intestinal bleeding in a 6-year-old girl with fascioliasis. Trop Geogr Med 1986;38: 429-31.
6. Jones EA, Kay JM, Milligan HP, Owens D. Massive infection with Fasci ola hepatica in man. Am J Med 1977;63:836-42.
7. Hillyer GV, Soler de Galanes M, Rodriguez-Perez J, et al. Use of the Falcon assay screening test-enzyme-linked immunosorbent assay (FAST-ELISA) and the enzyme-linked immunoelectrotransfer blot (EITB) to determine the prevalence of human fascioliasis in the Bolivian Altiplano. Am J Trop Med Hyg 1992;46:603-9.
8. Stork MG, Venables GS, Jennings SMF, Beesley JR. Bendezu P, Capron A. An investigation of endemic fascioliasis in Peruvian village children. J Trop Med Hyg 1973;76:231-5.
9. Farag HF, Salem A, El-Hifni SA, Kandil M. Bithionol (Bitin) treatment in established fascioliasis in Egyptians. J Trop Med Hyg 1988; 91: 240-4.
10. Nik-Akhtar B, Tabibi V. Metronidazole in fascioliasis: report of four cases. J Trop Med Hyg 1977;80:179-80.
11. Farid Z, Kamal M, Mansour N. Praziquantel and Fasciola hepatica infec tion. Trans R Soc Trop Med Hyg 1989;83:813.
12. Farid Z, Kamal M, Woody J. Treatment of acute toxaemic fascioliasis. Trans R Soc Trop Med Hyg 1988; 82:299.
13. Farid Z, Trabolsi B, Boctor F, Hafez A. Unsuccessful use of praziquantel to treat acute fascioliasis in children [letter]. J Infect Dis 1986; 154: 920-1.
14. Knobloch J, Delgado E, Alvarez A, Reymann U, Bialek R. Human fascioli asis in Cajamarca/Peru. I. Diagnostic methods and treatment with praziquantel. Trop Med Parasitol 1985;36:88-90.
15. Wessely K, Reischig HL, Heinermann M. Two cases of human fascioliasis and their successful treatment with triclabendazole (Fasinex). Proceedings from the Interdisciplinary Conference on Primary Health Care in the Tropics, Tropical Diseases and Zoonoses, 13- 15 April 1987. Geneva, Switzerland. Trop Med Parasitol 1987;38:265.
16. Coles GC. Anthelmintic activity of triclabendazole. J Helminthol 1986;60:210-2.
17. Loutan L, Bouvier M, Rojanawisut B, et al. Single treatment of invasive fascioliasis with triclabendazole [letter]. Lancet 1989;2:383.
18. Markwalder K, Kolier M, Goebel N, Wolff K. Infektion mit Fasciola hepatica’. erfolgreiche Therapie mit Triclabendazol. Schweiz Med Wochenschr 1988;118:1048-52.
19. Wessely K, Reischig HL, Heinerman M, Stempka R. Human fascioliasis treated with triclabendazole (Fasinex) for the first time. Trans R Soc Trop Med Hyg 1988;82:743-4.
20. Boray JC. Crowfoot PD, Strong MB, et al. Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. Vet Rec 1983;113:315-7.
21. Bennett JL, Kohler P. Fasciola hepatica’. action in vitro of triclabendazole on immature and adult stages. Exp Parasitol 1987:63:49-57.
22. Fawcett AR. A study of a restricted programme of strategic dosing against Fasciola hepatica with triclabendazole. Vet Rec 1990; 127:492-3.
23. Hillyer GV, Soler de Galanes M. Identification of a 17-kilodalton Fasciola hepatica immunodiagnostic antigen by the enzyme-linked immunoelectrotransfer blot technique. J Clin Microbiol 1988;26:2048-53.
24. Hillyer GV, Soler de Galanes M. Initial feasibility studies of the FAST- ELISA for the immunodiagnosis of fascioliasis.1 Parasitol 1991: 77:362-5.
25. Katz N. Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosoma mansoni. Rev Inst Med Trop Sao Paulo 1972; 14:397-400.
26. Goodman MA, Henderson JI, Cullity GJ. Fascioliasis causing jaundice and intestinal bleeding. Med J Aust 1973;2:547-50.
27. Acuna-Soto R. Braun-Roth G. Bleeding ulcer in the common bile duct due to Fasciola hepatica. Am J Gastroenterol 1987;82:560-2.
28. Boray JC. Fascioliasis and other trematode infections: recent advances in research on fasciola and other trematodes of animals. In: Slusarski W, ed. Review of advances in parasitology. Warszawa: PWN-Polish Scientific Publishers. 1981:317-39.